Compare stocks

MPH Health Care AG, established in 2008 and headquartered in Berlin, Germany, is an investment holding company focusing on the acquisition, development, and sale of companies within the healthcare sector, particularly in areas such as chronic diseases, medical aesthetic treatments, and healthcare digitalization. Its portfolio includes M1 Kliniken AG, specializing in aesthetic and plastic medical services; HAEMATO AG, a pharmaceutical company concentrating on off-patent and patent-protected drugs; and CR Capital AG, involved in real estate development. MPH Health Care AG's strategic approach emphasizes long-term value creation through active development of its investments, aiming to provide cost-effective services and products of high quality.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.